Silexion Therapeutics Corp SLXN 深 沪
等待开盘 10-06 09:30:00 美东时间
0.266
+0.006
+2.35%
华盛通- 最 高0.6303
- 今 开0.2605
- 成交量 111.65万股
- 最 低 0.2362
- 昨 收 0.2599
- 总市值 0
- 52周最高 5.45
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.231
- 委 比 -33.33%
- 总股本 --
- 历史最高 22.36
- 量 比 0.02
- 振 幅 151.64%
- 历史最低 0.2097
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Silexion Therapeutics To Raise $837K Via Exercise Of ~3.217M Series E Warrants At $0.2603/Share
Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the
09-29 20:11
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The
09-24 20:05
Silexion Therapeutics Announces 1-For-10 Reverse Share Split Of Ordinary Shares, Effective May 28
Silexion Therapeutics Corp. (NASDAQ:SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced a 1-for-10 reverse
05-26 20:33
Dow Tumbles 500 Points; NY Manufacturing Activity Surges In May
Dow Jones falls 500 points, S&P drops 1.29%, NASDAQ down 1.79%. Energy shares rise 1.2%, tech stocks fall 2.2%. NY Empire State Manufacturing Index at 19.6.
05-15 21:57
Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, Colorectal, and Lung Cancers
Silexion’s RNAi therapy SIL204 shows potent anti-tumor activity across KRAS-driven cancers including colorectal, lung, and pancreatic types, with up to 90% inhibition, expanding its potential for treating多种KRAS-driven cancers.
2025-05-29 13:05
Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer
Silexion completes preclinical study assessing SIL204's potential for treating KRAS-driven colorectal, lung, and pancreatic cancers, targeting an over $30 billion market.
2025-05-21 12:45
Market-Moving News for September 24th
MSS: 163% | Maison Solutions shares are trading higher after the company reported a year-over-year increase in Q1 sales results. LBRDA: 22% | Liberty Broadband shares are trading higher after the company
2024-09-24 20:07
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Shares of Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) rose sharply in...
2024-09-11 17:16
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM). Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in tod...
2024-09-04 01:41
